Correlation Between Pfizer and Capricor Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Capricor Therapeutics, you can compare the effects of market volatilities on Pfizer and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Capricor Therapeutics.

Diversification Opportunities for Pfizer and Capricor Therapeutics

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pfizer and Capricor is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of Pfizer i.e., Pfizer and Capricor Therapeutics go up and down completely randomly.

Pair Corralation between Pfizer and Capricor Therapeutics

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.4 times more return on investment than Capricor Therapeutics. However, Pfizer Inc is 2.51 times less risky than Capricor Therapeutics. It trades about -0.21 of its potential returns per unit of risk. Capricor Therapeutics is currently generating about -0.14 per unit of risk. If you would invest  2,802  in Pfizer Inc on August 30, 2024 and sell it today you would lose (219.00) from holding Pfizer Inc or give up 7.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  Capricor Therapeutics

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Capricor Therapeutics 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Capricor Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Capricor Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pfizer and Capricor Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and Capricor Therapeutics

The main advantage of trading using opposite Pfizer and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.
The idea behind Pfizer Inc and Capricor Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules